The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G(2)/M progression - PubMed (original) (raw)
. 1999 Oct:112 ( Pt 19):3361-71.
doi: 10.1242/jcs.112.19.3361.
Affiliations
- PMID: 10504341
- DOI: 10.1242/jcs.112.19.3361
The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G(2)/M progression
N J Wells et al. J Cell Sci. 1999 Oct.
Abstract
Activation of Cdc2, is the universal event controlling the onset of mitosis. In higher eukaryotes, Cdc2 activity is in part regulated by inhibitory phosphorylation of Thr14 and Tyr15, catalyzed by Wee1 and Myt1, which prevents catastrophic premature entry into mitosis. In this study we defined the function of Myt1 by overexpression studies in both S. pombe and a human osteosarcoma cell line. Similar to Wee1, overexpression of human Myt1 prevented entry into mitosis in both cell types; however, Myt1 catalytic activity was not essential for the cell cycle delay observed with human cells. Myt1 expression was restricted to proliferating cells. Furthermore, we detected no major decline in Myt1 protein abundance prior to the entry into mitosis, which coincides with the loss of Myt1 activity. We localized mitotic phosphoepitopes, recognized by the monoclonal antibody MPM-2, to the C-terminal domain of Myt1. The mitotic peptidyl-prolyl isomerase, Pin1, was able to associate with this domain in a phosphorylation-dependent manner. Truncation of the C-terminal domain of Myt1 prevented its ability to induce G(2)/M phase arrest in overexpression studies in human cells and dramatically reduced its ability to phosphorylate Cdc2 in vitro. We demonstrate that the C-terminal domain of Myt1 was required for recruitment of Cdc2, and we infer that this domain lies in the cytoplasm because it can interact with and is phosphorylated by Cdc2. In conclusion, we propose that Myt1 can negatively regulate Cdc2/cyclin B1 and inhibit G(2)/M progression by two means, both of which require the C-terminal domain; first, Myt1 can bind and sequester Cdc2/cyclin B1 in the cytoplasm preventing entry into the nucleus, and, second, it can phosphorylate associated Cdc2/cyclin B1 at Thr14 and Tyr15 thus inhibiting its catalytic activity.
Similar articles
- Myt1: a Wee1-type kinase that phosphorylates Cdc2 on residue Thr14.
Fattaey A, Booher RN. Fattaey A, et al. Prog Cell Cycle Res. 1997;3:233-40. doi: 10.1007/978-1-4615-5371-7_18. Prog Cell Cycle Res. 1997. PMID: 9552418 Review. - The xenopus Suc1/Cks protein promotes the phosphorylation of G(2)/M regulators.
Patra D, Wang SX, Kumagai A, Dunphy WG. Patra D, et al. J Biol Chem. 1999 Dec 24;274(52):36839-42. doi: 10.1074/jbc.274.52.36839. J Biol Chem. 1999. PMID: 10601234 - Overproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-cyclin B1 complexes.
Liu F, Rothblum-Oviatt C, Ryan CE, Piwnica-Worms H. Liu F, et al. Mol Cell Biol. 1999 Jul;19(7):5113-23. doi: 10.1128/MCB.19.7.5113. Mol Cell Biol. 1999. PMID: 10373560 Free PMC article. - Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity.
Booher RN, Holman PS, Fattaey A. Booher RN, et al. J Biol Chem. 1997 Aug 29;272(35):22300-6. doi: 10.1074/jbc.272.35.22300. J Biol Chem. 1997. PMID: 9268380 - Regulation of Cdc2 activity by phosphorylation at T14/Y15.
Berry LD, Gould KL. Berry LD, et al. Prog Cell Cycle Res. 1996;2:99-105. doi: 10.1007/978-1-4615-5873-6_10. Prog Cell Cycle Res. 1996. PMID: 9552387 Review.
Cited by
- Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery.
Lu KP, Zhou XZ. Lu KP, et al. Sci Signal. 2024 Jun 18;17(841):eadi8743. doi: 10.1126/scisignal.adi8743. Epub 2024 Jun 18. Sci Signal. 2024. PMID: 38889227 Review. - Wnt signaling couples G2 phase control with differentiation during hematopoiesis in Drosophila.
Goins LM, Girard JR, Mondal BC, Buran S, Su CC, Tang R, Biswas T, Kissi JA, Banerjee U. Goins LM, et al. Dev Cell. 2024 Sep 23;59(18):2477-2496.e5. doi: 10.1016/j.devcel.2024.05.023. Epub 2024 Jun 11. Dev Cell. 2024. PMID: 38866012 - Ginger Root Bioactive Compounds Specifically Inhibits Growth of Colon Cancer Cells in Culture.
Lin S, Lu P. Lin S, et al. Nutr Metab Insights. 2024 May 15;17:11786388241231163. doi: 10.1177/11786388241231163. eCollection 2024. Nutr Metab Insights. 2024. PMID: 38756503 Free PMC article. - Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents.
Lang F, Cornwell JA, Kaur K, Elmogazy O, Zhang W, Zhang M, Song H, Sun Z, Wu X, Aladjem MI, Aregger M, Cappell SD, Yang C. Lang F, et al. Neuro Oncol. 2024 Jun 3;26(6):1083-1096. doi: 10.1093/neuonc/noad252. Neuro Oncol. 2024. PMID: 38134889 - Myt1 overexpression mediates resistance to cell cycle and DNA damage checkpoint kinase inhibitors.
Sokhi S, Lewis CW, Bukhari AB, Hadfield J, Xiao EJ, Fung J, Yoon YJ, Hsu WH, Gamper AM, Chan GK. Sokhi S, et al. Front Cell Dev Biol. 2023 Nov 2;11:1270542. doi: 10.3389/fcell.2023.1270542. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38020882 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous